Archives for the 'feature2' Category
In an effort to improve its cost structure and conserve cash, Minrad International said it would layoff 35 percent of its workforce, or some 50 jobs. The layoffs come after a dismal third quarter. Despite […]
21 November 2008 |
Blog, Member Spotlight, news1, feature2 |
Regular Sentinel readers know I’m a fan of Endologix. The developer of a minimally invasive treatment for abdominal aortic aneurysms has had a slate of positive news of late. In addition to two new FDA […]
13 November 2008 |
Blog, news1, feature2 |
In a recent filing, Cyberkinetics Neurotechnology said it only had enough cash to last 30 days. If negotiations fail with its secured creditor, GE Capital, the company will shut down and may seek bankruptcy protection.
At […]
7 November 2008 |
Blog, news1, Video, feature2 |
Having acquired onetime rival Diomed for a song, AngioDynamics has launched a new varicose vein therapy brand, VenaCure EVLT. The new brand combines AngioDynamics’ VenaCure with Diomed’s EVLT.
“As the name conveys, our new brand will […]
6 November 2008 |
Blog, news2, feature2 |
The FDA has approved ATS Medical’s 3f Aortic Bioprosthesis (3fAB), a poorly named, but potentially revolutionary pericardial aortic tissue valve.
3fAB’s blood flow dynamics and improved stress distribution mimic the functional characteristics of the native valve, […]
31 October 2008 |
Blog, news1, feature2 |
Only months after Langer sold its Bi-Op subsidiary for less than its purchase price, the company announced the sale of its custom orthotics business to The Orthotic Group (TOG), a manufacturer of prescription custom foot […]
27 October 2008 |
Blog, news2, feature2 |
Endologix, developer of a treatment for abdominal aortic aneurysms (AAA), saw revenues increase 42% in its third quarter. The company reported $9.4 million in sales and expects “at least” $10 million in fourth quarter revenue. […]
24 October 2008 |
Blog, news1, feature2 |
An infusion of capital will help NeoChord go the distance. Previously, the company had raised $1.76 million from angel investors in a convertible debt offering. Clarian Health Ventures, an Indiana-based fund, made the investment. The […]
15 October 2008 |
Blog, Member Spotlight, news2, feature2 |
A Texas jury has found that Palomar’s products do not infringe on a Candela patent.
Candela had accused eight Palomar handpieces of infringing on three Candela Patents. Curiously, just days before the start of trial, Candela […]
10 October 2008 |
Blog, news2, feature2 |
The AP has a tendency to turn any earnings misstep into a headline. Such was the case with yesterday’s news that “AngioDynamics 1Q profit slips on lower laser sales”. The Business Review said, “AngioDynamics reports […]
3 October 2008 |
Blog, news1, feature2 |
